David Sans
Keine laufenden Positionen mehr
Vermögen: 2 930 $ am 30.04.2024
Profil
David Sans worked as the Head of Business Development at ImClone LLC and as the Chief Corporate Development at Calidi Biotherapeutics, Inc. He holds a doctorate degree from Ramon Llull University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 12.09.2023 | 18 314 ( 0,05% ) | 2 930 $ | 30.04.2024 |
Ehemalige bekannte Positionen von David Sans
| Unternehmen | Position | Ende |
|---|---|---|
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Direktor/Vorstandsmitglied | - |
| CALIDI BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ausbildung von David Sans
| Ramon Llull University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CALIDI BIOTHERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
